Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Lpath suspends dosing in clinical studies of iSONEP

Jan. 27, 2012

No Comments

NovaBay prepares to start phase IIb NVC-422 trial

Jan. 25, 2012

No Comments

Treatment begins in Europe's first clinical study of hESC-derived cell therapy

Jan. 24, 2012

No Comments

Seikagaku launches phase II SI-614 study

Jan. 24, 2012

No Comments

Otuska launches ophthalmic suspension in Japan

Jan. 11, 2012

No Comments

Quark Pharmaceuticals reports first-in-human data on siRNA drug candidate

Jan. 5, 2012

No Comments

MacuCLEAR raises funds and enters partnership for lead AMD treatment

Jan. 4, 2012

No Comments

Gene therapy for wet AMD enters phase I/II testing

Jan. 2, 2012

No Comments

RegeneRx aims to close licensing deal for ophthalmic drug candidate

Dec. 30, 2011

No Comments

New study investigates fixed-dose combination therapies for elevated IOP

Dec. 29, 2011

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Lpath suspends dosing in clinical studies of iSONEP

NovaBay prepares to start phase IIb NVC-422 trial

Treatment begins in Europe's first clinical study of hESC-derived cell therapy

Seikagaku launches phase II SI-614 study

Otuska launches ophthalmic suspension in Japan

Quark Pharmaceuticals reports first-in-human data on siRNA drug candidate

MacuCLEAR raises funds and enters partnership for lead AMD treatment

Gene therapy for wet AMD enters phase I/II testing

RegeneRx aims to close licensing deal for ophthalmic drug candidate

New study investigates fixed-dose combination therapies for elevated IOP

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Ocular RSS

Ocular
RSS